Cited by 10Ubiquitin and proteasome pathwaysProtein Degradation and InhibitorsPI3K/AKT/mTOR signaling in cancer

Diaryl Disulfides as Novel Stabilizers of Tumor Suppressor Pdcd4

Open access
Schmid, Tobias, Blees, Johanna S., Bajer, Magdalena M., Wild, Janine, Pescatori, Luca, Cuzzucoli Crucitti, Giuliana, Scipione, Luigi, Costi, Roberta +4 more·2016·PLOS ONE

Abstract

The translation inhibitor and tumor suppressor Pdcd4 was reported to be lost in various tumors and put forward as prognostic marker in tumorigenesis. Decreased Pdcd4 protein stability due to PI3K-mTOR-p70S6K1 dependent phosphorylation of Pdcd4 followed by β-TrCP1-mediated ubiquitination, and proteasomal destruction of the protein was characterized as a major mechanism contributing to the loss of Pdcd4 expression in tumors. In an attempt to identify stabilizers of Pdcd4, we used a luciferase-based high-throughput compatible cellular assay to monitor phosphorylation-dependent proteasomal degradation of Pdcd4 in response to mitogen stimulation. Following a screen of approximately 2000 compounds, we identified 1,2-bis(4-chlorophenyl)disulfide as a novel Pdcd4 stabilizer. To determine an initial structure-activity relationship, we used 3 additional compounds, synthesized according to previous reports, and 2 commercially available compounds for further testing, in which either the linker between the aryls was modified (compounds 2-4) or the chlorine residues were replaced by groups with different electronic properties (compounds 5 and 6). We observed that those compounds with alterations in the sulfide linker completely lost the Pdcd4 stabilizing potential. In contrast, modifications in the chlorine residues showed only minor effects on the Pdcd4 stabilizing activity. A reporter with a mutated phospho-degron verified the specificity of the compounds for stabilizing the Pdcd4 reporter. Interestingly, the active diaryl disulfides inhibited proliferation and viability at concentrations where they stabilized Pdcd4, suggesting that Pdcd4 stabilization might contribute to the anti-proliferative properties. Finally, computational modelling indicated that the flexibility of the disulfide linker might be necessary to exert the biological functions of the compounds, as the inactive compound appeared to be energetically more restricted.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0151643

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Schmid, T., Blees, J. S., Bajer, M. M., Wild, J., Pescatori, L., Cuzzucoli Crucitti, G., Scipione, L., Costi, R., Henrich, C. J., Brüne, B., Colburn, N. H., & Di Santo, R.
Affiliations
  • Goethe University Frankfurt (DE)
  • Istituto Pasteur (IT)
  • Frederick National Laboratory for Cancer Research (US)
Corresponding author
Schmid, Tobias
Venue
PLOS ONE
Published
2016-03-16
Volume
11
Issue
3
Pages
e0151643
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2298225921
Cited by
10
References
25
Citations by year
2023: 2 · 2022: 2 · 2020: 1 · 2019: 3 · 2017: 1 · 2016: 1
FWCI
0.87
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, public-domain)
  • PubMed Central (publishedVersion, public-domain)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Publikationsdatenbank der Fraunhofer-Gesellschaft (Fraunhofer-Gesellschaft) (submittedVersion, other-oa)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion, cc-by)
  • Fraunhofer-Publica (Fraunhofer-Gesellschaft) (submittedVersion)
  • Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) (submittedVersion, cc-by)
Funders
  • Frederick National Laboratory for Cancer Research (HHSN261200800001E.)
  • Deutsche Forschungsgemeinschaft (SCHM2663, HHSN261200800001E, GRK1172, SCHM 2663/3)
  • National Institutes of Health (#HHSN261200800001E, HHSN261200800001C)
  • National Cancer Institute (HHSN261200800001E))
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Keywords
PDCD4, diaryl disulfides, protein stabilization, tumor suppressor, β-TrCP1, proteasomal degradation, structure-activity relationship, antiproliferative activity, structure-based drug design
MeSH terms
Cell Cycle, Humans, Structure-Activity Relationship, Sulfides, RNA-Binding Proteins, Tumor Suppressor Proteins, Cell Proliferation, Apoptosis Regulatory Proteins, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review